Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dynamic Biotechnology & Genome Invesco ETF (PBE)

Dynamic Biotechnology & Genome Invesco ETF (PBE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 237,214,000
  • Market Capitalization, $K 237,214
  • Shares Outstanding, K 4,150
  • 60-Month Beta 1.30
  • Price/Earnings ttm 11.94
  • Annual Dividend & Yield 0.03 (0.05%)
  • Most Recent Dividend 0.029 on 03/23/20
  • Management Fee 0.57%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.10 +13.57%
on 05/01/20
60.00 -3.27%
on 05/26/20
+3.87 (+7.15%)
since 04/29/20
3-Month
38.08 +52.41%
on 03/18/20
60.00 -3.27%
on 05/26/20
+7.94 (+15.84%)
since 02/28/20
52-Week
38.08 +52.41%
on 03/18/20
60.00 -3.27%
on 05/26/20
+8.67 (+17.56%)
since 05/29/19

Most Recent Stories

More News
Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSK : 41.92 (+0.91%)
PBE : 58.04 (+1.45%)
ARKG : 46.34 (+2.32%)
GNOM : 16.51 (+0.84%)
IDNA : 35.88 (+1.47%)
Biotech ETFs to Gain From Latest Advancements in Cancer Drugs

The rising incidence of cancer cases has encouraged several major pharmaceutical and biotech players to invest substantially in the developments of drugs.

AZN : 54.60 (+2.06%)
PFE : 38.19 (+0.03%)
MRK : 80.72 (+2.13%)
LLY : 152.95 (+1.53%)
MYGN : 14.53 (+0.83%)
IMMU : 33.59 (+0.87%)
IBB : 134.74 (+1.82%)
CNCR : 26.49 (+2.75%)
XBI : 103.56 (+0.99%)
PBE : 58.04 (+1.45%)
Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir

As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.

GILD : 77.83 (+3.33%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
BBH : 160.91 (+2.60%)
PBE : 58.04 (+1.45%)
First-Mover Pandemic Disease Fight ETF On The Way

Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.

REGN : 612.81 (+5.98%)
GILD : 77.83 (+3.33%)
IMMU : 33.59 (+0.87%)
SBIO : 41.50 (+0.58%)
PBE : 58.04 (+1.45%)
MYOK : 102.29 (+2.14%)
IOVA : 32.09 (-1.75%)
ARKG : 46.34 (+2.32%)
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

GILD : 77.83 (+3.33%)
IBB : 134.74 (+1.82%)
CNCR : 26.49 (+2.75%)
BBH : 160.91 (+2.60%)
FBT : 165.41 (+1.14%)
PTH : 114.10 (+1.46%)
IHF : 200.10 (-0.43%)
IHE : 157.43 (+0.87%)
XPH : 43.20 (-0.09%)
SBIO : 41.50 (+0.58%)
XHS : 69.96 (-0.06%)
PBE : 58.04 (+1.45%)
IDNA : 35.88 (+1.47%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 58.04 (+1.45%)
JNJ : 148.75 (+1.21%)
LLY : 152.95 (+1.53%)
BMY : 59.72 (-0.15%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 58.04 (+1.45%)
JNJ : 148.75 (+1.21%)
BMY : 59.72 (-0.15%)
LLY : 152.95 (+1.53%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 58.04 (+1.45%)
BMY : 59.72 (-0.15%)
JNJ : 148.75 (+1.21%)
LLY : 152.95 (+1.53%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

CNCR : 26.49 (+2.75%)
BBC : 41.15 (+0.59%)
PBE : 58.04 (+1.45%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
SBIO : 41.50 (+0.58%)
IDNA : 35.88 (+1.47%)
HTEC : 29.81 (+0.93%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 58.04 (+1.45%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
BIIB : 307.09 (+2.19%)
VRTX : 287.96 (+3.81%)
NBIX : 124.76 (+3.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PBE with:

Fund Summary

The Invesco Dynamic Biotechnology and Genome ETF is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating...

See More

Key Turning Points

2nd Resistance Point 59.13
1st Resistance Point 58.58
Last Price 58.04
1st Support Level 56.98
2nd Support Level 55.92

See More

52-Week High 60.00
Last Price 58.04
Fibonacci 61.8% 51.63
Fibonacci 50% 49.04
Fibonacci 38.2% 46.45
52-Week Low 38.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar